Riffyn will be attending AccBio 2019 in Carlsbad, California from February 17-19. This conference series is dedicated to strategies, technologies and capabilities that accelerate biopharmaceutical development.
Riffyn CEO, Tim Gardner will be speaking at BPI West, on March 14, 2019 at 10:55 AM in Santa Clara, CA:
Title: Overcoming data silos in process development: batch data to multivariate analysis in 30s
Please visit us at the talk, or contact us to set up a time to meet.
Riffyn will attend the Pistoia Alliance’s first ever Bay Area Networking Reception on February 5. The event will be held at the Accenture Innovation Hub in Salesforce Tower in San Francisco.
Riffyn CEO, Tim Gardner, will present the keynote address on synthetic biology, industrial biotechnology and the transformative impact of digitization of life sciences
Riffyn's Director of Science, Laura Jennings-Antipov, will join fellow panelists Terry Stouch (CSO, Science for Solutions), Ketan Patel (Industry Consultant, Teradata), and Jamie Powers (Sr. Director, Cambridge Semantics), to discuss challenges and recent advancements in data quality, availability, and accessibility. Join us!
Join Riffyn, Amazon Web Services (AWS), and an esteemed panel of thought leaders from GSK, Amyris, Novartis, BASF & DRx Capital for an afternoon/evening of food/cocktails and discussion of machine learning & AI in the life sciences. AWS & Riffyn will provide brief introductions to their toolkits for experiment design, data shaping / integration, and machine learning / AI. This will be followed by a panel discussion of the rapid advance of machine learning & AI in biotech and pharmaceutical R&D. Free and open to anyone (with pre-registration).
Join us for a case study of Riffyn SDE in action. Riffyn scientists will demonstrate how the SDE can take you from lab data to machine learning in 30 seconds.
Join us at Synbiobeta 2018 for an opening keynote on October 2 by Riffyn CEO, Tim Gardner: Twenty Years of Synthetic Biology: 1998 to 2018.
Join us for presentations on Riffyn SDE by Riffyn's Commercial Director, Doug Williams. Also see use cases with Riffyn SDE presented by Søren Egestad and Katrine Skeby from Novozymes R&D. And we are also hosting a booth. Stop by to say hello and see Riffyn SDE up close!
Want to go from lab data to machine learning in 30 seconds? Join us for the launch of SynBioBetaLive!, a web event we’re premiering on Wednesday, May 23 at 8 am Pacific. Our CEO Timothy Gardner kicks off the inaugural event, to demonstrate and discuss how biological researchers can spend less time organizing their experimental data and more time asking important questions about it.
Today's research and development breakthroughs lie deep in the midst of complex, multivariate data sets. Experimental anomalies and fundamental discoveries often go unnoticed because they are buried in uninterpretable spreadsheets, inaccessible databases, or excessive experimental noise. Riffyn SDE software structures experimental designs and links it to measurement data for machine learning within seconds after it is collected in the lab.
Today's research and development breakthroughs lie deep in the midst of complex, multivariate data sets. Experimental anomalies and fundamental discoveries often go unnoticed because they are buried in uninterpretable spreadsheets, inaccessible databases, or excessive experimental noise. The cloud-based Riffyn SDE software structures experimental designs and links it to measurement data for machine learning within seconds after it is collected in the lab. We will demonstrate how biotech companies are using this capability to identify unexpected correlations in animal studies, uncover root causes of error in screening experiments, and deliver right-first-time technology scale-up in bioprocess development.
Tim Gardner will speak at the National Academies of Sciences, Engineering, and Medicine one-day meeting and webcast on "Improving Reproducibility by Teaching Data Science as a Scientific Process". This meeting will bring together data scientists and educators in academia and industry to 1) discuss how data science can help understand and improve reproducibility of scientific research, and 2) learn about several courses and training offerings for reproducible data science.
Be sure to catch Tim Gardner's presentation in Technology Workshop 3: "Laboratory Data to Machine Learning in 30 seconds". In this presentation we will demonstrate how biotech companies are using Riffyn to identify unexpected correlations, uncover root causes of error, and deliver right-first-time technology scale-up.
Join us at the Bioprocessing Summit 2017 in Boston, MA
Riffyn CEO, Tim Gardner, presents an on-demand webinar on Adaptive Process Design, Automation & Analytics in Laboratory R&D.
Join us at Bio-IT World Conference 2017! CEO Tim Gardner will speak as part of the pre-conference workshop, Data Management for Biologics: Registration and Beyond.
Join us at SmartLab Exchange 2017 in San Diego, CA: Where IT and Science Meet to Enhance Performance, Integration and Quality in the Laboratory
Join Tim Gardner from Riffyn at SLAS 2017, where he will chair a session in the Data Analysis and Informatics Track on enhancing scientific reproducibility and reuse through better workflow and data technologies. Drawing from the experiences of speakers in academia, government, and industry, this session emphasizes the use of enhanced workflows, quality management systems, and data utilization to improve experimental rigor and data reproducibility in research and development.
Riffyn CEO Timothy Gardner will present a keynote focused on industrial scale-ups on 15 December 2016 at the first IET /SynbiCITE Conference on Engineering Biology 2016 in London.
Chairman Professor Richard Kitney will welcome engineers, academics and students to the IET/SynBiCITE Engineering Biology Conference 2016 taking place at the newly refurbished IET London: Savoy Place. This three day conference will provide a platform for the international synthetic biology community to hear and present their leading edge research in Synthetic Biology and how these findings are being adopted by industry.
Riffyn will attend the Life Sciences Future conference in Philadelphia, PA. Life Sciences Future has been heralded as the best and most important life sciences event in the mid-Atlantic region. To meet Riffyn at the conference please contact us!
Riffyn is proud to sponsor SynBioBeta SF 2016, the prime conference for the synthetic biology industry – bringing the global community together to drive technology and business forward. Fuel your passion for engineering biology with a program full of talks from key thought-leaders, decision makers and tech pioneers. SynBioBeta is a must for those wanting to keep up with the rapidly-evolving industry.
California is a haven for the life sciences industry. Come join Riffyn at CA Pavilion starting June 7!
Riffyn co-founder, Matt Cockerill, will discuss Riffyn's technology for making design, quality, reusability, versioning and realtime analytics as inherent to scientific experimentation as it is to software, cars, airplanes and electronics. Matt will also discuss how Riffyn is incorporating the Allotrope Data Format as a core technology for exchanging data and methodological information via an open data standard.
Riffyn will co-host an exhibit with Siemens at Hannover Messe, the world’s leading trade fair for industrial technology.
Whole-cell models are promising tools for predicting phenotype from genotype by accounting for every individual gene and cell function. The goal of the 2016 Whole-Cell Modeling Summer School is to provide young investigators cutting-edge training in large-scale dynamical modeling and model integration.
Riffyn is presenting at the Allotrope Foundation Cross-Industry workshop hosted by Genentech in South San Francisco. Event is open to anyone. Register here.
Riffyn will provide a view of its iterative R&D process design and data analytics capabilities, and describe how we are integrating the Allotrope Framework to enable standardized import and export of designs, data and knowledge.
Riffyn CEO, Tim Gardner, presented Riffyn's vision for the next wave in the timeline of Synthetic Biology advancement: Measure Systems. He showed how Riffyn is helping pave its software for visual design and sharing of experiments and processes in life sciences and chemistry. Riffyn's offers a kind-of "source code control" software for laboratory research processes - capabilities the company hopes will advance a new era of open source science.
Riffyn is a member of the Allotrope Partner Network (APN) and will be joining the APN workshop on September 15 in Chicago to help define the tools and standards for scientific instrument data exchange. The Allotrope Foundation is an international association of pharmaceutical and biotech companies dedicated to the building of a “Laboratory Framework” to improve efficiency in data acquisition, archiving, and management.
Riffyn and PLOS are hosting the @MozillaScience #mozsprint June 4-5, in Oakland and SF. Join us to help #openscience: https://etherpad.mozilla.org/sciencelab-2015globalsprint
Help us build on ResourceMiner, Riffyn's open project to develop a natural language processing toolkit for extracting controlled vocabularies (ontologies) of research resources used in the scientific literature, and organizing them into an associative knowledge graph.
In April and May, the Royal Society held a series of discussions on evolving and controversial areas in scholarly communication, looking at the impact of technology, the culture of science and how scientists might communicate in the future. Matt Cockerill presented Riffyn's vision of that future and the role of design and quality engineering in improving reproducibility and reusability of scientific results.
Riffyn co-founder Matt Cockerill will be participating in a panel session on Reliable Quality and Reproducibility at the 10th Academic Publishing in Europe conference.
The APE 2015 Conference Program will offer a broad perspective, varying from research excellence, peer reviewing, use of information, content innovation, funding and investing, business models, new types of information, enabling technologies, repositories, search engines, dissemination, access and sharing of knowledge.
